Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression ; volume:8 ; number:1 ; day:4 ; month:5 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (4.5.2018), 1-14, 12.2018
- Creator
-
Brohée, Laura
- Contributor
-
Peulen, Olivier
Nusgens, Betty
Castronovo, Vincent
Thiry, Marc
Colige, Alain C.
Deroanne, Christophe F.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25340-9
- URN
-
urn:nbn:de:101:1-2018070223055216823259
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brohée, Laura
- Peulen, Olivier
- Nusgens, Betty
- Castronovo, Vincent
- Thiry, Marc
- Colige, Alain C.
- Deroanne, Christophe F.
- SpringerLink (Online service)
Other Objects (12)
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine